Crohn Disease (CD)
Conditions
Keywords
Crohn's disease, intestinal ultrasound, bowel wall thickness
Brief summary
Transabdominal intestinal ultrasound (IUS) is gaining acceptance as a point-of-care test to objectively assess disease activity in Crohn's disease (CD). In order to incorporate individual parameters in a future definition of transmural healing, and for the consistent application of IUS as a modality to assess treatment outcomes and establish therapeutic targets to ensure comparability between future studies, the inter-observer agreement should be determined for all relevant parameters.
Interventions
Transabdominal intestinal ultrasound
Sponsors
Centre Hospitalier Universitaire, Amiens
Study design
Allocation
NON_RANDOMIZED
Intervention model
SINGLE_GROUP
Primary purpose
OTHER
Masking
NONE
Eligibility
Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
* Crohn's disease evolving for at least 1 months * Patient older than 18 years * Patient covered by French national health insurance * Written informed consent
Exclusion criteria
* Pregnant women or breastfeeding * Minor * Patient deprived of liberty by administrative or judicial decision or placed under judicial protection (guardianship or supervision)
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Number of different IUS parameters between two operators | 1 year | To assess in patients with CD the variability of IUS parameters between two operators |
Countries
France
Contacts
Primary ContactMathurin Fumery, Pr
Outcome results
None listed